9,9-Dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine>95.0%(HPLC)(N)1g

2-(4-CHLOROPHENYL)-2-(PIPERIDIN-1-YL)ACETIC ACID HCL, 95.0%, 250mg

1-(2-Furylmethyl)-5-oxopyrrolidine-3-carboxylic acid, 95.0%, 1g

3-(3-fluorophenyl)piperazin-2-one, 95.0%, 5g

Methyl 2,4-dihydroxy-3,6-dimethylbenzoate, 95.0%, 100g

Carbinol terminated(ethyleneoxide)-(dimethylsiloxane)-(ethyleneoxide) block copolymer cSt 400-450, 100g

3-Bromo-2-iodobenzoic acid, 95.0%, 250mg

2-Chloro-3-methylbenzaldehyde, 95.0%, 10g

4-(Dimethylamino)but-2-enoic acid hydrochloride, 98% (only trans), 100g

4,4',4''-(1,3,5-Triazine-2,4,6-triyl)tribenzaldehyde, 97%, 250mg

2-(1-((tert-Butoxycarbonyl)amino)cyclobutyl)acetic acid, 95.0%, 500mg

(1-Ethylpiperidin-4-yl)methanol, 95.0%, 10g

(S)-5-((9H-Fluoren-9-yl)methoxy)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxopentanoic acid, 97%, 5g